The pharmaceutical industry is on a journey to create more diverse and inclusive working cultures. Read the article to find out more.

How can pharma companies improve inclusivity across their R&D cycles?

Biotechs have stood as agile hubs for drug discovery, but now they are being coveted by investors.

The amount of digital content being created for healthcare professionals has grown exponentially. Medical affairs teams must find a way to cut through the noise with their communications

As the pharmaceutical industry embraces digital transformation, new technologies have the potential to sink or swim. How can the industry ensure it’s backing the most effective innovations and not getting stuck in dead ends?

The COVID-19 pandemic has reshaped pharmaceutical sales, moving from face-to-face to predominantly digital interactions. How can sales reps adapt to multichannel approaches and enhance performance amidst this shift in sales training and team dynamics?

The pharmaceutical industry’s digital transformation during the pandemic has fuelled fresh opportunities to collect and harness data, but this venture must be approached with a strong consideration for consent and preference management rules

An interview with Tamika-Jean Baptiste, Vice President and Chief Diversity Officer, Amgen.